Origin and Diversification of TRIM Ubiquitin Ligases

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Marín, Ignacio ^a  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPARTITE MOTIF PROTEIN; TRIPARTITE MOTIF PROTEIN 1; TRIPARTITE MOTIF PROTEIN 14; TRIPARTITE MOTIF PROTEIN 18; TRIPARTITE MOTIF PROTEIN 19; TRIPARTITE MOTIF PROTEIN 2; TRIPARTITE MOTIF PROTEIN 20; TRIPARTITE MOTIF PROTEIN 29; TRIPARTITE MOTIF PROTEIN 3; TRIPARTITE MOTIF PROTEIN 31; TRIPARTITE MOTIF PROTEIN 32; TRIPARTITE MOTIF PROTEIN 36; TRIPARTITE MOTIF PROTEIN 40; TRIPARTITE MOTIF PROTEIN 44; TRIPARTITE MOTIF PROTEIN 45; TRIPARTITE MOTIF PROTEIN 46; TRIPARTITE MOTIF PROTEIN 52; TRIPARTITE MOTIF PROTEIN 54; TRIPARTITE MOTIF PROTEIN 55; TRIPARTITE MOTIF PROTEIN 56; TRIPARTITE MOTIF PROTEIN 61; TRIPARTITE MOTIF PROTEIN 63; TRIPARTITE MOTIF PROTEIN 67; TRIPARTITE MOTIF PROTEIN 73; TRIPARTITE MOTIF PROTEIN 74; TRIPARTITE MOTIF PROTEIN 76; TRIPARTITE MOTIF PROTEIN 8; TRIPARTITE MOTIF PROTEIN 9; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DATABASE; PROTEIN DOMAIN; PROTEIN FAMILY; SPECIES DIFFERENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, INNATE; MEMBRANE PROTEINS; MUTATION; PHYLOGENY; PROTEIN FOLDING; RING FINGER DOMAINS; UBIQUITIN-PROTEIN LIGASES;

ALVEOLATA; ANIMALIA; APUSOZOA; EUKARYOTA; FUNGI;

EID: 84869767918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050030     Document Type: Article

References (97)

1. Glickman MH, Ciechanover A, (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428.
2. Kerscher O, Felberbaum R, Hochstrasser M, (2006) Modification of proteins by ubiquitin and ubiquitin-like. Annu Rev Cell Dev Biol 22: 159-180.
3. Chen ZJ, Sun LJ, (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33: 275-286.
4. Komander D, (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37: 937-953.
5. Schwartz AL, Ciechanover A, (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49: 73-96.
6. Behrends C, Harper JW, (2011) Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol 18: 520-528.
7. Marín I, (2009) Diversification of the cullin family. BMC Evol Biol 9: 267.
8. Marín I, (2010) Animal HECT ubiquitin ligases: evolution and functional implications. BMC Evol Biol 10: 56.
9. Marín I, (2010) Ancient origin of animal U-box ubiquitin ligases. BMC Evol Biol 10: 331.
10. Deshaies RJ, Joazeiro CA, (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399-434.
11. Marín I, Lucas JI, Gradilla AC, Ferrús A, (2004) Parkin and relatives: the RBR family of ubiquitin ligases. Physiol Genomics 17: 253-263.
12. Marín I, Ferrús A, (2002) Comparative genomics of the RBR family, including the Parkinson's disease-related gene parkin and the genes of the ariadne subfamily. Mol Biol Evol 19: 2039-2050.
13. Lucas JI, Arnau V, Marín I, (2006) Comparative genomics and protein domain graph analyses link ubiquitination and RNA metabolism. J Mol Biol 357: 9-17.
14. Marín I, (2009) RBR ubiquitin ligases: Diversification and streamlining in animal lineages. J Mol Evol 69: 54-64.
15. Marín I, (2010) Diversification and specialization of plant RBR ubiquitin ligases. PLoS One 5: e11579.
16. Wenzel DM, Lissounov A, Brzovic PS, Klevit RE, (2011) UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474: 105-108.
17. Torok M, Etkin LD, (2001) Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation 67: 63-71.
18. Meroni G, Diez-Roux G, (2005) TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27: 1147-1157.
19. Nisole S, Stoye JP, Saïb A, (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3: 799-808.
20. Ozato K, Shin DM, Chang TH, Morse HC 3rd (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8: 849-860.
21. McNab FW, Rajsbaum R, Stoye JP, O'Garra A, (2011) Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 23: 46-56.
22. Massiah MA, Matts JA, Short KM, Simmons BN, Singireddy S, et al. (2007) Solution structure of the MID1 B-box2 CHC(D/C)C(2)H(2) zinc-binding domain: insights into an evolutionarily conserved RING fold. J Mol Biol 369: 1-10.
23. Sardiello M, Cairo S, Fontanella B, Ballabio A, Meroni G, (2008) Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol 8: 225.
24. van der Aa LM, Levraud JP, Yahmi M, Lauret E, Briolat V, et al. (2009) A large new subset of TRIM genes highly diversified by duplication and positive selection in teleost fish. BMC Biol 7: 7.
25. Boudinot P, van der Aa LM, Jouneau L, Du Pasquier L, Pontarotti P, et al. (2011) Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish. PLoS One 6: e22022.
26. Tae H, Casarotto MG, Dulhunty AF, (2009) Ubiquitous SPRY domains and their role in the skeletal type ryanodine receptor. Eur Biophys J 39: 51-59.
27. Du Pasquier L, (2009) Fish 'n' TRIMs. J Biol 8: 50.
28. Avela K, Lipsanen-Nyman M, Idänheimo N, Seemanová E, Rosengren S, et al. (2000) Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. Nat Genet 25: 298-301.
29. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, et al. (1997) Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 17: 285-291.
30. Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, et al. (2002) Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 70: 663-672.
31. Chiang AP, Beck JS, Yen HJ, Tayeh MK, Scheetz TE, et al. (2006) Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci U S A 103: 6287-6292.
32. Saccone V, Palmieri M, Passamano L, Piluso G, Meroni G, et al. (2008) Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H. Hum Mutat 29: 240-247.
33. French FMF Consortium, (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17: 25-31.
34. The International FMF Consortium, (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797-807.
35. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, et al. (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7: 1317-1325.
36. Keech CL, Howarth S, Coates T, Rischmueller M, McCluskey J, et al. (1996) Rapid and sensitive detection of anti-Ro (SS-A) antibodies by indirect immunofluorescence of 60 kDa Ro HEp-2 transfectants. Pathology 28: 54-57.
37. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, et al. (2005) Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201: 11-17.
38. Kurata R, Nakaoka H, Tajima A, Hosomichi K, Shiina T, et al. (2010) TRIM39 and RNF39 are associated with Behçet's disease independently of HLA-B*51 and-A*26. Biochem Biophys Res Commun 401: 533-537.
39. Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ, (2008) Deregulated protein kinase A signaling and myospryn expression in muscular dystrophy. J Biol Chem 283: 8070-8074.
40. Balastik M, Ferraguti F, Pires-da Silva A, Lee TH, Alvarez-Bolado G, et al. (2008) Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci U S A 105: 12016-12021.
41. Shi H, Medway C, Bullock J, Brown K, Kalsheker N, et al. (2010) Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD). Int J Mol Epidemiol Genet 1: 53-66.
42. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, et al. (1988) Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3: 571-578.
43. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, et al. (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14: 2020-2033.
44. Corcoran MM, Hammarsund M, Zhu C, Lerner M, Kapanadze B, et al. (2004) DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer 40: 285-297.
45. Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, et al. (2006) Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 118: 1954-1962.
46. Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, et al. (2007) The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell 18: 1670-1682.
47. Karlberg S, Lipsanen-Nyman M, Lassus H, Kallijärvi J, Lehesjoki AE, et al. (2009) Gynecological tumors in Mulibrey nanism and role for RING finger protein TRIM37 in the pathogenesis of ovarian fibrothecomas. Mod Pathol 22: 570-578.
48. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, et al. (2009) DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med 6: e1000068.
49. Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, et al. (2009) Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 15: 207-219.
50. Hatakeyama S, (2011) TRIM proteins and cancer. Nat Rev Cancer 11: 792-804.
51. Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de Thé H, (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72: 1043-1051.
52. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
53. Yap MW, Nisole S, Lynch C, Stoye JP, (2004) Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101: 10786-10791.
54. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, et al. (2004) TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101: 11827-11832.
55. Bouazzaoui A, Kreutz M, Eisert V, Dinauer N, Heinzelmann A, et al. (2006) Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 356: 79-94.
56. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, et al. (2006) PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80: 7995-8005.
57. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T, (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80: 8006-8018.
58. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920.
59. Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, et al. (2008) Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci U S A 105: 16743-16748.
60. Wolf D, Goff SP, (2007) TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131: 46-57.
61. Ammermann I, Bruckner M, Matthes F, Iftner T, Stubenrauch F, (2008) Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules. J Virol 82: 5127-5136.
62. Wolf D, Hug K, Goff SP, (2008) TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc Natl Acad Sci U S A 105: 12521-12526.
63. Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, et al. (2008) Restriction of foamy viruses by primate Trim5alpha. J Virol 82: 5429-5439.
64. Uchil PD, Quinlan BD, Chan WT, Luna JM, Mothes W, (2008) TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog 4: e16.
65. Chang PC, Fitzgerald LD, Van Geelen A, Izumiya Y, Ellison TJ, et al. (2009) Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Cancer Res 69: 5681-5689.
66. Eldin P, Papon L, Oteiza A, Brocchi E, Lawson TG, et al. (2009) TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J Gen Virol 90: 536-545.
67. Gao B, Duan Z, Xu W, Xiong S, (2009) Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50: 424-433.
68. Wolf D, Goff SP, (2009) Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 458: 1201-1204.
69. Poole E, Groves I, MacDonald A, Pang Y, Alcami A, et al. (2009) Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J Virol 83: 3581-3590.
70. Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, et al. (2010) Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci U S A 107: 15856-15861.
71. Kajaste-Rudnitski A, Marelli SS, Pultrone C, Pertel T, Uchil PD, et al. (2011) TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. J Virol 85: 5183-5196.
72. Taylor RT, Lubick KJ, Robertson SJ, Broughton JP, Bloom ME, et al. (2011) TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase. Cell Host Microbe 10: 185-196.
73. Wang J, Liu B, Wang N, Lee YM, Liu C, et al. (2011) TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection. J Virol 85: 3733-3745.
74. Zou W, Zhang DE, (2006) The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J Biol Chem 281: 3989-3994.
75. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, et al. (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112: 381-393.
76. Chu Y, Yang X, (2011) SUMO E3 ligase activity of TRIM proteins. Oncogene 30: 1108-1116.
77. Short KM, Cox TC, (2006) Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J Biol Chem 281: 8970-8980.
78. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
79. Katoh K, Toh H, (2008) Recent developments in the MAFFT multiple sequence alignment program. Briefings Bioinf 9: 286-298.
80. Nicholas KB, Nicholas HB Jr (1997) GeneDoc: a tool for editing and annotating multiple sequence alignments. Distributed by the authors.
81. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731-2739.
82. Swofford DL (2003) PAUP*. Phylogenetic Analysis Using Parsimony (* and Other Methods). Version 4. Sinauer Associates, Sunderland, Massachusetts.
83. Dwivedi B, Gadagkar SR, (2009) Phylogenetic inference under varying proportions of indel-induced alignment gaps. BMC Evol Biol 9: 211.
84. Zdobnov EM, Apweiler R, (2001) InterProScan- an integration platform for the signature-recognition methods in InterPro. Bioinformatics 17: 847-848.
85. Zapata JM, Martínez-García V, Lefebvre S, (2007) Phylogeny of the TRAF/MATH domain. Adv Exp Med Biol 597: 1-24.
86. Ye H, Park YC, Kreishman M, Kieff E, Wu H, (1999) The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 4: 321-330.
87. Bradley JR, Pober JS, (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491.
88. Wajant H, Henkler F, Scheurich P, (2001) The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13: 389-400.
89. Chung JY, Park YC, Ye H, Wu H, (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115: 679-688.
90. Pineda G, Ea CK, Chen ZJ, (2007) Ubiquitination and TRAF signaling. Adv Exp Med Biol 597: 80-92.
91. Gentry MS, Dixon JE, Worby CA, (2009) Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem Sci 34: 628-639.
92. Romá-Mateo C, Moreno D, Vernia S, Rubio T, Bridges TM, et al. (2011) Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level. BMC Evol Biol 11: 225.
93. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
94. Xia ZP, Sun L, Chen X, Pineda G, Jiang X, et al. (2009) Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461: 114-119.
95. Zeng W, Sun L, Jiang X, Chen X, Hou F, et al. (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141: 315-330.
96. Garcia-Gonzalo FR, Rosa JL, (2005) The HERC proteins: functional and evolutionary insights. Cell Mol Life Sci 62: 1826-1838.
97. Hes FJ, Morreau H, (2009) Where genetics and pathology meet: mulibrey nanism. J Pathol 218: 143-145.